doctor-image
Clarified Precision Medicine and xCures Form Strategic Partnership to Transform Patient Outcomes Through Precision Oncology

New collaboration will focus on analyzing and improving guidelines-based utilization of precision medicine to better support oncologists and cancer patients.

Bringing the Human Factor to the “Last Mile” of AI-Assisted Clinical Decisions

This article from the AJMC - The American Journal of Managed Care captures how we’re solving the last mile in precision medicine for clinicians and patients. Our unique combination of artificial intelligence (AI) and medical expertise makes the difference.

doctor-image
Under the Microscope: Clarified Precision Medicine

Avestria Ventures invested in Clarified Precision Medicine because the company fills a critical oncology need with an advanced solution and, in the process, bridges the gap between genomic testing and care, making genomically-informed precision medicine available, accessible, and actionable.

doctor-image
Clarified Precision Medicine Raises $1.2M in Seed Round

Clarified Precision Medicine on Tuesday said it has raised $1.2 million in a seed financing round, which it will put toward advancing its virtual molecular tumor board model and help more patients and providers gain access to guidelines-based precision oncology treatments.

doctor-image
Clarified Precision Medicine Raises $1.2 Million in Seed Funding and Appoints Health Tech Leader Rajni Natesan, MD, MBA as CEO

Clarified Precision Medicine, the only company that provides oncologists with prioritized therapy options via a combination of algorithmic testing and physician oversight, announced that it closed on its seed round of $1.2 million led by Avestria Ventures, with participation from Joyance Partners, both early-stage funds focused on improving health. The company also named Rajni Natesan, MD, MBA as its Chief Executive Officer.

doctor-image
VieCure Launches Pilot Program with Clarified Precision Medicine at ALCC to Accelerate the Adoption of Precision Oncology

With a focus on patients and community oncologists, the partners will turn a greater number of molecular test tesults Into actionable therapy.

doctor-image
CCF ANNOUNCES PARTNERSHIP WITH CLARIFIED PRECISION MEDICINE

Partnership to Provide Expert Precision Oncology Review for Neuroendocrine Cancer Patients.

doctor-image
DR. ROY BEVERIDGE JOINS CLARIIFI MANAGING BOARD

Former Chief Medical Officer (CMO) of US Oncology Network and Humana to provide oversight and expertise to growing precision medicine company.

doctor-image
DR. RICHARD SCHILSKY JOINS CLARIIFI MANAGING BOARD

Former Chief Medical Officer (CMO) and Executive Vice President of ASCO to provide guidance and support to growing precision medicine company.